id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-0129-0010,FDA,FDA-2012-N-0129,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; General Licensing
Provisions; Section 351(k) Biosimilar Applications",Notice,30 Day Proposed Information Collection,2015-07-01T04:00:00Z,2015,7,2015-07-01T04:00:00Z,2015-08-01T03:59:59Z,2015-07-01T14:17:59Z,2015-16128,0,0,0900006481b61af0
FDA-2012-N-0129-0006,FDA,FDA-2012-N-0129,"Agency Information Collection Activities; Proposed Collection;
Comment Request; General Licensing Provisions; Section 351(k) Biosimilar Applications",Notice,60 Day Proposed Information Collection,2015-02-03T05:00:00Z,2015,2,2015-02-03T05:00:00Z,2015-04-07T03:59:59Z,2015-04-23T02:01:59Z,2015-02025,0,0,09000064819ef83e